Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma
Clinical trial NCT01241162 · COMPLETED
Trial details
- NCT number
- NCT01241162
- Sponsor
- University of Louisville
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2016-10-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.